Allergy & Immunology Doctors in Rancho Mirage, CA Accepting Medicare

5 Allergy & Immunology doctors found. Showing 1 - 5

Ranjeet Minocha, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 39000 Bob Hope Dr Ste K304, Rancho Mirage, CA 92270 Phone: 760-346-2070    Fax: 760-346-4495

Dr. David John Waldman, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 39935 Vista Del Sol Ste 100, Rancho Mirage, CA 92270 Phone: 760-568-3595    Fax: 760-779-8671

Dr. Aqil P Imam, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 69844 Highway 111, Rancho Mirage, CA 92270 Phone: 760-318-4869    Fax: 760-770-1608

Dr. Vincent Patrick Devlin Jr., DO, MHS Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 39000 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-346-2070    Fax: 760-346-4495

Sam Jay Weiss, M.D. Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 39000 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-346-2070    Fax: 760-346-4495

News Archive

GAA calls on Obama to fund for PEPFAR

International Human Rights Day - At his Nobel Peace Prize acceptance speech in Oslo, Norway, this morning, President Barack Obama emphasized the importance of health and access to medicines for all people as a prerequisite to security. The President said:

Low wind speeds and stale air associated with higher incidence of Covid-19

While it may not be the season for beach going and barbecues, people continue to work and gather outside in many settings. Is that cause for concern in these latest stages of the pandemic, and new variants? Not necessarily, but a new study indicates that low wind speeds and stale air are associated with a higher incidence of contracting Covid-19 when people socialize outside – perhaps as much as 45 percent more compared to when winds are stronger.

Data from pivotal study of Marqibo in ALL patients to be presented at ASCO meeting

Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that complete data from its pivotal study of Marqibo in patients with relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia, have been accepted for an oral podium presentation at the 46th Annual Meeting of the American Society of Clinical Oncology to be held June 4-8, 2010 in Chicago, Illinois.

New digital platform to aid young Aussies living with incurable movement disorder

More than 20,000 young Aussies (under 50 years of age) living with an incurable movement disorder are set to benefit from the launch of an Australian-first digital support platform today (Thursday, April 8, 2021), ahead of World Parkinson's Day (Sunday, April 11, 2021).

Modified classification system finds over one-third of knee replacements as inappropriate

New research reports that more than one third of total knee replacements in the U.S. were classified as "inappropriate" using a patient classification system developed and validated in Spain. The study, published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), highlights the need for consensus on patient selection criteria among U.S. medical professionals treating those with the potential need of knee replacement surgery.

Read more Medical News

› Verified 9 days ago